Weekly subcutaneous recombinant human erythropoietin corrects anemia of progressive renal failure
- 1 September 1991
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 91 (3) , 229-232
- https://doi.org/10.1016/0002-9343(91)90120-m
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Analysis of Initial Resistance of Erythropoiesis to Treatment with Recombinant Human ErythropoietinPublished by S. Karger AG ,2015
- Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietinThe American Journal of Medicine, 1990
- Recombinant human erythropoietin activates a broad spectrum of progenitor cellsKidney International, 1990
- Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal DiseaseAnnals of Internal Medicine, 1989
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- Comparative Pharmacokinetics of Recombinant Erythropoietin Administered by the Intravenous, Subcutaneous, and Intraperitoneal Routes in Continuous Ambulatory Peritoneal Dialysis (CAPD) PatientsPeritoneal Dialysis International, 1989
- Recombinant Human Erythropoietin Treatment in Pre-Dialysis PatientsAnnals of Internal Medicine, 1989
- SUBCUTANEOUS ERYTHROPOIETINThe Lancet, 1988
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987